H2AX and hepatocellular carcinoma: (38) discovered that UBE2T was increased in HCC tissues, and that HCC sufferers with greater UBE2T quantities have a worse prognosis, demonstrating that UBE2T-regulated H2AX mono-ubiquitination may induce hepatocellular carcinoma radiation resistance by boosting CHK1 activation.